Showing 1 posts of 1 posts found.
Novartis will have to significantly lower the price of its meningococcal B vaccine if it wants a lucrative UK inoculation …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO